Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Easton Pharmaceuticals announces closing of agreement to invest and acquire ownership interest in AMFIL Technologies Inc and the mPact -GROzone Antimicrobial Systems Line of Products


Tuesday, 8 Jul 2014 01:30pm EDT 

Easton Pharmaceuticals Inc:Announces that it has advanced funds and closed on an agreement to invest and purchase an ownership interest in AMFIL Technologies Inc and the mPact -GROzone Antimicrobial Systems Line of Products.Agreement includes an option to purchase warrants allowing Easton to purchase an additional ownership interest up to 32.5 pct of AMFIL. 

Company Quote

0.01
 --
10:37am EDT